A comprehensive review of the relationship between autophagy and sorafenib-resistance in hepatocellular carcinoma: ferroptosis is noteworthy

Patients with hepatocellular carcinoma (HCC) bear a heavy burden of disease and economic burden but have fewer treatment options. Sorafenib, a multi-kinase inhibitor, is the only approved drug that can be used to limit the progression of inoperable or distant metastatic HCC. However, enhanced autoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kangnan, Zhang, Qinghui, Jia, Rongrong, Xiang, Shihao, Xu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172583/
https://www.ncbi.nlm.nih.gov/pubmed/37181755
http://dx.doi.org/10.3389/fcell.2023.1156383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172583/
https://www.ncbi.nlm.nih.gov/pubmed/37181755
http://dx.doi.org/10.3389/fcell.2023.1156383

Ejemplares similares